YOUR KEY PARTNER FOR MARKET ACCESS

IN SPAIN

PRICING&REIMBURSEMENT,NATIONAL AND REGIONALMARKET ACCESS IN SPAIN

RCAPharma is the spanish partner of:

WE HELP PHARMACEUTICAL COMPANIES TO:

∙ Develop successful P&R strategies ∙ Establish optimal value messages to achieve optimal pricing

∙ Maximize market access opportunities ∙ Minimize time to listing on drug formularies ∙ Develop comprehensive intelligence on Spanish market and stakeholders involved

BY: ∙ Capturing the value of the product and developing effective price strategies

∙ Leveraging RCA extensive experience and longstanding relationships with payers and price regulators

∙ Integrating value propositions and stakeholders into the P&R process and regional decision making procedures

pharmapriceinternational

For more information on our services please contact: c pilar.sanchez@rcapharma.com c www.rcapharma.com

RCAPharma, Pez Volador 15 1ºB 28007 Madrid SpainPhone: + 34 91 400 83 85 · Fax: + 34 91 400 83 86

A4_triptico_RCApharma_3_LOGONUEVO.indd 1-3 25/10/11 10:54

RCAPHARMARCAPharma is a pricing and market access consultancy established in 1991. The firm has extensive expertise with Spanish pricing and market access regulations, strategies and submissions. Our expertise and experience will provide your product with an integrated strategy for pricing and market access in Spain to overcome national and regional market access hurdles. RCAPharma has a close cooperation with national and regional decision makers and influencers and can establish the appropriate links with the best interlocutors according to the project characteristics.

OUR RANGE OF SERVICESP&R and Market Access Services

∙ Comprehensive intelligence about Spanish Market

∙ Definition of key value messages, optimal price and best launch sequence for Spain

∙ Pricing strategies and customized submissions to the Ministry of Health and/or Regional Health Departments, Hospitals or HTA Agencies

∙ Global Value Dossiers and Hospital Access Dossiers adapted to Spanish requirements

∙ Company representation during Price Discussions and Price Increase Applications

∙ Testing of key messages in Payer Advisory Boards with national and regional experts

Health Economics and Outcomes Research ∙ Pricing Studies. Potential impact of competitors in pricing opportunity

∙ Systematic market and literature reviews ∙ Qualitative and quantitative fieldwork with KOL and stakeholders

∙ Willingness to pay evaluations at national and regional level

∙ Budget Impact models and risk-sharing schemes adapted to the regional criteria

∙ Other Health Economic Evaluations and modeling

REGIONAL MARKET ACCESS IN SPAINRCAPharma can provide the necessary information to understand the changing regional Spanish environment by providing information about local procedures implemented, people involved and its sphere of influence, to achieve a successful market access in each Spanish region. RCAPharma has perfectly identified and maintains a close cooperation with decision makers, key influencers and implementers selecting the most appropriate interlocutors for each project. Thus, both product information and value messages can be tailored to the needs of the different regional stakeholders, maximizing market access opportunities and minimizing time to listing on regional formularies.

A4_triptico_RCApharma_3_LOGONUEVO.indd 4-6 25/10/11 10:54